Explore
Login
Register
/
Untitled
Clone
Register
Report Bug
Untitled
View
Untitled Deck
Study
Rheumatoid Arthritis (RA) Pathophysiology
RA is an autoimmune disease where the immune system attacks the synovium, causing joint inflammation, pain, and damage.
Rheumatoid Arthritis (RA) Epidemiology
RA is most commonly diagnosed in people between the ages of 40 and 60. Women are more frequently affected than men.
Rheumatoid Arthritis (RA) Signs and Symptoms
Includes pain, stiffness, and swelling, commonly affecting the MCP and PIP joints of the fingers, interphalangeal joints of the thumbs, the wrist, and MTP joints of the toes.
Rheumatoid Arthritis (RA) Diagnosis
Blood tests for ESR, CRP, HLAB27 protein, and rheumatoid factor. Elevated ESR and CRP indicate inflammation, and the presence of HLAB27 protein and rheumatoid factor increases the risk of developing autoimmune diseases or RA.
Rheumatoid Arthritis (RA) Treatment and Management
Treatment aims to reduce inflammation, alleviate pain, prevent joint damage, and improve the patient's quality of life. It may involve medications, physical therapy, lifestyle modifications, and surgical interventions.
Treatment Using the 5 Osteopathic Models: Biomechanical Model for RA
Focuses on the musculoskeletal system and may include osteopathic manipulative treatment (OMT) to improve joint function and alleviate pain.
Treatment Using the 5 Osteopathic Models: RespiratoryCirculatory Model for RA
Involves techniques to enhance blood flow and lymphatic drainage to reduce inflammation and promote healing in RA patients.
Treatment Using the 5 Osteopathic Models: Metabolic Model for RA
Considers the impact of nutrition and metabolism on health and may involve developing a dietary plan to support joint health and reduce inflammation in RA patients.
Juvenile Idiopathic Arthritis (JIA) Pathophysiology
JIA is a group of autoimmune conditions in children characterized by chronic joint inflammation.
Juvenile Idiopathic Arthritis (JIA) Epidemiology
JIA is the most common pediatric rheumatic disease and can start at any age, affecting both genders.
Juvenile Idiopathic Arthritis (JIA) Signs and Symptoms
Include joint pain, stiffness, tiredness, and fatigue, with relapsing and remitting disease patterns. It can also be associated with eye inflammation, skin changes, fever, and rash.
Juvenile Idiopathic Arthritis (JIA) Diagnosis
Involves blood tests for ESR, CRP, RF, ultrasound or MRI for joint inflammation, and X-ray for structural damage.
Juvenile Idiopathic Arthritis (JIA) Treatment and Management
Includes medications, physical therapy, lifestyle modifications, surgical interventions, and patient education to manage the condition in pediatric patients.
Treatment Using the 5 Osteopathic Models: Biomechanical Model for JIA
Focuses on joint mobility and alignment, possibly involving osteopathic manipulative treatment to improve joint function and reduce pain.
Treatment Using the 5 Osteopathic Models: RespiratoryCirculatory Model for JIA
Involves techniques to enhance circulation and lymphatic drainage to support healing and overall health in children with JIA.
Treatment Using the 5 Osteopathic Models: Metabolic Model for JIA
May include dietary modifications tailored to children's specific needs to address inflammation and provide essential nutrients for joint health in JIA patients.
Polymyalgia Rheumatica (PMR) Pathophysiology
PMR is an inflammatory disorder primarily affecting the shoulders and hips, with an unknown exact cause.
Polymyalgia Rheumatica (PMR) Epidemiology
Most commonly seen in individuals over the age of 50, with a higher prevalence in those of Northern European descent. It is more common in women than men, and the incidence increases with age.
Polymyalgia Rheumatica (PMR) Signs and Symptoms
Include pain, stiffness in proximal muscles of the shoulder and pelvic girdle, often with early morning stiffness. It may have systemic symptoms such as weight loss, malaise, and anorexia.
Polymyalgia Rheumatica (PMR) Diagnosis
Involves blood tests for ESR, CRP, and imaging (ultrasound, MRI) to distinguish from other causes of shoulder/pelvic pain.
Polymyalgia Rheumatica (PMR) Treatment and Management
The primary goal is to reduce inflammation and alleviate pain, typically involving corticosteroid medications such as prednisone. Osteopathic techniques may be used to improve joint mobility, reduce pain, and enhance musculoskeletal function.
Treatment Using the 5 Osteopathic Models: Biomechanical Model for PMR
Involves gentle osteopathic manipulative treatment (OMT) to improve joint mobility, reduce pain, and enhance musculoskeletal function.
Treatment Using the 5 Osteopathic Models: RespiratoryCirculatory Model for PMR
May include techniques to improve blood flow and cardiovascular health to support overall healing in PMR patients.
Treatment Using the 5 Osteopathic Models: Metabolic Model for PMR
Involves developing a dietary plan to support joint and muscle health, possibly focusing on anti-inflammatory foods to manage the underlying inflammation associated with PMR.
Gout Pathophysiology
Gout is a type of arthritis caused by the deposition of uric acid crystals in the joints, leading to inflammation.
Gout Epidemiology
Relatively common in developed countries, more prevalent in men aged 40 and above with certain risk factors such as obesity, purine-rich diet, and family history of gout.
Gout Signs and Symptoms
Include acute severe pain, swelling, redness, and hot, tender joints with a distal presentation. Episodes are recurrent and may last 3-10 days with periods of remission.
Gout Diagnosis
Involves arthrocentesis for urate crystals, serum uric acid blood tests, urinalysis, and imaging (X-ray, US, MRI) visualizing urate crystals.
Gout Treatment and Management
Aims to reduce pain and inflammation, achieve target serum urate levels, and educate patients on lifestyle modifications, dietary recommendations, hydration, and exercise.
Untitled Deck
Study
Ankylosing Spondylitis Pathophysiology
Ankylosing spondylitis is a chronic inflammatory arthritis primarily affecting the spine and sacroiliac joints. It often leads to spinal fusion and restricted mobility.
Ankylosing Spondylitis Epidemiology
It is more common in young men and has a genetic predisposition with the HLAB27 gene playing a significant role. Affects men 23x more than women. Median age 23yrs, rarely begins after 45yrs.
Ankylosing Spondylitis Signs and Symptoms
Lower aching back pain with morning stiffness, gel phenomenon, lower back, gluteal region and posterior thigh pain. May get nocturnal exacerbation. Better with exercise. No improvement with rest. Insidious onset. Poor spinal mobility.
Ankylosing Spondylitis Diagnosis
Blood test: CRP, ESR, HLAB27 (90+% ve), Plasma Viscosity. Xray, MRI.
Ankylosing Spondylitis Treatment and Management
Patient education, NSAIDs, DMARDs, local corticosteroids, weight management, exercise and stretching, physical therapy, fall prevention, psychological treatment.
5 Osteopathic Models for Ankylosing Spondylitis Treatment Plan
1. Biomechanical Model: OMT for improving spinal mobility. 2. Respiratory-Circulatory Model: Osteopathic techniques to improve blood flow and reduce inflammation. 3. Metabolic Model: Dietary guidance for managing inflammation. 4. Neurological Model: Addressing nervous system's role in pain management. 5. Behavioral Model: Counseling and stress management techniques.
Psoriatic Arthritis Pathophysiology
Psoriatic arthritis is an autoimmune condition often occurring in individuals with psoriasis. It leads to joint inflammation, skin lesions, and nail abnormalities.
Psoriatic Arthritis Epidemiology
It affects about 30% of people with psoriasis. Onset can occur at any age.
Psoriatic Arthritis Signs and Symptoms
Joint stiffness, swelling, and pain in 1 or more joints. Usually asymmetrical. Joints: DIPs, lower spine, SIJs. Tender enthesopathy, scaly inflamed patches of skin, dactylitis, nail bed pitting, fatigue, malaise.
Psoriatic Arthritis Diagnosis
CRP, ESR, RF +ve, Xray, MRI.
Psoriatic Arthritis Treatment and Management
Patient education, NSAIDs, DMARDs, local corticosteroids, weight management, exercise and stretching.
5 Osteopathic Models for Psoriatic Arthritis Treatment Plan
1. Biomechanical Model: OMT for affected joints. 2. Respiratory-Circulatory Model: Osteopathic techniques for improving circulation. 3. Metabolic Model: Dietary guidance for managing inflammation. 4. Neurological Model: Addressing nervous system's role in pain management. 5. Behavioral Model: Counseling and stress management techniques.
Reactive Arthritis Pathophysiology
Reactive arthritis is a form of arthritis triggered by an infection in another part of the body. It commonly affects joints, eyes, and urinary or gastrointestinal systems.
Reactive Arthritis Epidemiology
Most commonly in men 40 years or younger.
Reactive Arthritis Signs and Symptoms
Acute onset, urethritis, conjunctivitis, acute asymmetric oligoarthritis, painful joints, early myalgia, mild recurrent abdominal complaints.
Reactive Arthritis Diagnosis
CBC, ESR, CRP, serology, urinalysis, HIV, ECG, Xray, MRI, US, PET Scan.
Reactive Arthritis Treatment and Management
Antibiotics if underlying infection is identified, NSAIDs, corticosteroids, physical therapy.
5 Osteopathic Models for Reactive Arthritis Treatment Plan
1. Biomechanical Model: OMT for affected joints. 2. Respiratory-Circulatory Model: Osteopathic techniques for improving circulation. 3. Metabolic Model: Dietary guidance for managing inflammation. 4. Neurological Model: Addressing nervous system's role in pain management. 5. Behavioral Model: Counseling and stress management techniques.
Enteropathic Arthritis Pathophysiology
Enteropathic arthritis is associated with inflammatory bowel diseases (IBD) such as Crohn's disease and ulcerative colitis. It often involves joint inflammation in conjunction with gut symptoms.
Enteropathic Arthritis Epidemiology
Occurs in 1-5% of people with IBD. Arthritis is estimated to occur in up to 46% of patients with IBD. Most common in 15-35 yrs.
Enteropathic Arthritis Signs and Symptoms
Axial involvement, peripheral joint involvement, GI symptoms, joint deformity, pain, inflammation, morning stiffness in back/buttocks.
Enteropathic Arthritis Diagnosis
CBC, ESR, CRP, RF absent, Synovial Fluid analysis, Xray, MRI, US, Bone Scintigraphy.
Enteropathic Arthritis Treatment and Management
Referral to rheumatologist and gastroenterologist for management. Minimize pain, optimize function, and beneficially modify the process of joint damage. Initial treatment with NSAID, DMARDs, local glucocorticoid injections, surgery if needed.
5 Osteopathic Models for Enteropathic Arthritis Treatment Plan
1. Biomechanical Model: OMT for joint pain and inflammation. 2. Respiratory-Circulatory Model: Osteopathic techniques for improving circulation and supporting the immune response. 3. Metabolic Model: Dietary guidance for managing inflammation. 4. Neurological Model: Addressing nervous system's role in pain management. 5. Behavioral Model: Counseling and stress management techniques.
Untitled Deck
Study
Osteoarthritis OA Pathophysiology
OA is a degenerative joint disease characterised by the breakdown of joint cartilage and underlying bone. It typically results from wear and tear on joints over time but can also be influenced by genetics and other factors.
Osteoarthritis OA Epidemiology
Age, gender, family history, genetics, obesity/overweight, repetitive use, previous inflammatory arthritis, diabetes mellitus, sedentary lifestyle, occupation are factors influencing osteoarthritis.
Osteoarthritis OA Signs and Symptoms
Deep aching joint pain, aggravated by extensive use, pain and stiffness after rest or inactivity, morning stiffness (>30 mins), swelling, range of motion restrictions, and crepitus. Common in hands, DIPs, thumb, knees, hips, cervical and lumbar spine.
Osteoarthritis OA Diagnosis
No specific tests. Full blood count (FBC) for comorbidities, erythrocyte sedimentation rate (ESR) not elevated, synovial fluid analysis, X-ray, bone scan.
Osteoarthritis OA Treatment and Management
Pain relief through over-the-counter or prescription medications (e.g., acetaminophen, NSAIDs), physical therapy, lifestyle modifications, intra-articular injections, surgical interventions in advanced cases.
Osteoarthritis OA Treatment Using the 5 Osteopathic Models
1. Biomechanical Model: Address musculoskeletal issues through osteopathic manipulative treatment (OMT). 2. Respiratory/Circulatory Model: Encourage regular physical activity and deep breathing exercises. 3. Metabolic/Energy Model: Monitor metabolic health and provide nutritional guidance. 4. Neurological Model: Assist in pain management and address psychological impact. 5. Behavioral Model: Promote lifestyle changes for overall health.
Osteoporosis Pathophysiology
Osteoporosis is a systemic bone disease characterized by reduced bone density and quality. It occurs when the rate of bone resorption (breakdown) exceeds the rate of bone formation, resulting in weakened and porous bones.
Osteoporosis Epidemiology
Common in postmenopausal women and the elderly, can also affect people of all ages and genders. Risk factors include smoking, prior fragility fracture, rheumatoid arthritis, coeliac disease, chronic liver or kidney disease, and underlying diseases.
Osteoporosis Signs and Symptoms
Often a silent disease with no outward symptoms until fracture occurs. Vertebral fractures may be painless or present with acute, self-limiting back pain. Peripheral fractures, stress fractures.
Osteoporosis Diagnosis
Bone mineral density (BMD) measured by DXA (gold standard test), X-ray not sensitive and requires 30% bone loss to see.
Osteoporosis Treatment and Management
Medications (bisphosphonates, hormone therapy, denosumab), calcium and vitamin D supplementation, lifestyle modifications, fall prevention strategies, and patient education.
Osteoporosis Treatment Using the 5 Osteopathic Models
1. Biomechanical Model: Emphasize weight-bearing exercises and osteopathic manipulative treatment (OMT). 2. Respiratory/Circulatory Model: Encourage cardiovascular health and deep breathing exercises. 3. Metabolic/Energy Model: Monitor nutritional intake for calcium and vitamin D support. 4. Neurological Model: Assist in pain management and psychological factors. 5. Behavioral Model: Support lifestyle changes for bone health.
Fibromyalgia (FMS) Pathophysiology
Chronic condition characterized by widespread pain and tenderness, along with issues such as fatigue, sleep disturbances, memory problems, and mood issues.
Fibromyalgia (FMS) Epidemiology
More common in women, usual age of onset 29-37 years, but usual diagnosis age is 44-53 years. Associated with repetitive injury, family history, and systemic lupus erythematosus (SLE).
Fibromyalgia (FMS) Signs and Symptoms
Widespread pain and stiffness, hyperalgesia, varying quality of pain, fatigue, depression, anxiety, sleep disorder, cognitive dysfunction, headaches/migraine, tingling or numbness, digestive disorders.
Fibromyalgia (FMS) Diagnosis
Considered with widespread chronic pain, fatigue, sleep problems, cognitive disturbances, depression, headaches, and abdominal pain. CBC, CRP, ESR may be normal.
Fibromyalgia (FMS) Treatment and Management
Patient education, medications, physical therapy, sleep management, and lifestyle modifications. Utilize cognitive-behavioral therapy (CBT) for symptom management.
Fibromyalgia (FMS) Treatment Using the 5 Osteopathic Models
1. Biomechanical Model: Utilize osteopathic manipulative treatment (OMT) to reduce pain and improve joint mobility. 2. Respiratory/Circulatory Model: Encourage physical activity and relaxation techniques. 3. Metabolic/Energy Model: Monitor and optimize nutritional intake. 4. Neurological Model: Provide support for managing pain and cognitive factors. 5. Behavioral Model: Encourage lifestyle changes for overall wellbeing.
Chronic Fatigue Syndrome (CFS) Pathophysiology
Complex illness with unknown pathophysiology. Possible factors include viral infections, genetics, and immune dysfunction. Characterized by profound fatigue, sleep disturbances, pain, and cognitive impairment.
Chronic Fatigue Syndrome (CFS) Epidemiology
Common in women, young to middle-aged adults. Symptoms worsened by exertion, with no improvement from rest. Diagnosis based on clinical suspicion with symptoms persisting for 3 months.
Chronic Fatigue Syndrome (CFS) Signs and Symptoms
Profound fatigue, sleep disturbances, pain, cognitive impairment, no improvement with rest, exacerbated symptoms with physical and mental exertion, dizziness upon sitting up.
Chronic Fatigue Syndrome (CFS) Diagnosis
No specific tests. Clinical diagnosis based on symptoms persisting for 3 months. Tests may include FBC, electrolytes, ESR, CRP, and urinalysis.
Chronic Fatigue Syndrome (CFS) Treatment and Management
Lifestyle modifications, cognitive-behavioral therapy, graded exercise therapy, and medications for symptom management.
Chronic Fatigue Syndrome (CFS) Treatment Using the 5 Osteopathic Models
1. Biomechanical Model: Use osteopathic manipulative treatment (OMT) for pain management and joint mobility. 2. Respiratory/Circulatory Model: Encourage physical activity within limits and relaxation techniques. 3. Metabolic/Energy Model: Monitor and optimize nutritional intake and address sleep disturbances. 4. Neurological Model: Support for managing cognitive difficulties and psychological factors. 5. Behavioral Model: Encourage lifestyle changes and realistic goals for activity.
Pagets Disease (PDB) Pathophysiology
Chronic and progressive skeletal disorder characterized by abnormal bone remodeling, excessive bone resorption, and disorganized bone formation. Leads to weakened, enlarged, and misshapen bones.
Pagets Disease (PDB) Epidemiology
Second most common metabolic disorder of bone after osteoporosis. More common in older adults, with the highest prevalence in individuals over the age of 55, more common in men.
Pagets Disease (PDB) Signs and Symptoms
Asymptomatic in 70-90% of cases. Main symptoms related to abnormal areas of bone remodeling, bone bending, enlargement, pain, fractures, joint pain, hearing loss.
Untitled Deck
Study
Systemic Lupus Erythematosus (SLE)
Pathophysiology: An autoimmune disease where the body attacks its own tissues, causing widespread inflammation and tissue damage. Epidemiology: Typically affects young women of childbearing age. Signs and symptoms: Fatigue and malaise, joint pain and swelling, skin rashes such as the characteristic butterfly rash, photosensitivity, kidney problems, chest pain, neurological symptoms, haematological abnormalities. Diagnosis: ANA, dsDNA, ESR, CRP, urinalysis, CBC, X-ray, chest radiography, US, ECG, CT scan, MRI. Treatment and management: Medications, immunosuppressive medications, sun protection, lifestyle modifications, monitoring for organ involvement, osteopathic treatment plan using the 5 Osteopathic Models.
Ehlers Danlos Syndrome (EDS)
Pathophysiology: EDS is a group of inherited connective tissue disorders characterized by a genetic mutation affecting collagen production. Epidemiology: Rare condition affecting skin, joints, blood vessels, and other structures. Signs and symptoms: Skin hyperelasticity, joint hypermobility, atrophic scarring, blood vessel fragility, joint pain, dislocation, muscle weakness. Diagnosis: Genetic testing, skin biopsy, X-ray, US, MRI, CT scan. Treatment and management: Physical therapy, pain management, occupational therapy, supportive measures, osteopathic treatment plan using the 5 Osteopathic Models.
Marfan's Syndrome (MFS)
Pathophysiology: A genetic disorder affecting the body's connective tissues, characterized by loss of elastic tissue. Epidemiology: Relatively rare genetic disorder affecting men and women of all ethnic backgrounds. Signs and symptoms: Long limbs, abnormally long digits, skeletal deformities, reduced joint mobility, joint laxity. Diagnosis: Molecular genetic sequencing, ECG, genetic screening, X-ray, MRI, ECG. Treatment and management: Monitoring and managing cardiovascular complications, orthopedic interventions, ophthalmological care, lifestyle modifications, osteopathic treatment plan using the 5 Osteopathic Models.
Osteogenesis Imperfecta (OI)
Pathophysiology: A rare connective tissue disease characterized by extremely fragile and easily fractured bones, caused by a defect in collagen synthesis or structure. Epidemiology: Relatively rare condition affecting individuals of all races and ethnic backgrounds. Signs and symptoms: Frequent bone fractures, short stature, blue or gray tint to the whites of the eyes, skeletal deformities, brittle teeth, hearing loss, joint hypermobility. Diagnosis: Genomic sequence analysis, genetic testing, X-ray, MRI, bone mineral density. Treatment and management: Medications, physical therapy, orthopedic interventions, dental care, hearing aids, osteopathic treatment plan using the 5 Osteopathic Models.
Untitled Deck
Study
Parkinsons Disease Pathophysiology
Parkinson's Disease is a neurodegenerative disorder characterized by the progressive loss of dopamine-producing neurons in the brain, primarily in the substantia nigra. The exact cause is believed to involve a combination of genetic and environmental factors. The reduction of dopamine leads to motor and non-motor symptoms including tremors, bradykinesia, rigidity, and postural instability.
Parkinsons Disease Epidemiology
Parkinson's Disease is the second most common neurodegenerative disorder after Alzheimer's disease. It predominantly affects individuals over the age of 60, with the risk increasing with age. It is estimated that approximately 1-2% of people over the age of 65 are living with Parkinson's Disease.
Parkinsons Disease Signs and Symptoms
The signs and symptoms of Parkinson's Disease include tremors, bradykinesia, rigidity, postural instability, as well as non-motor symptoms such as depression, anxiety, sleep disturbances, and cognitive impairment.
Parkinsons Disease Diagnosis
The diagnosis of Parkinson's Disease is often based on UK Brain Bank Criteria and may involve a dopamine agent trial and DaTSCAN to confirm the loss of brain cells containing dopamine. Brain scans such as MRI and CT scans may appear normal.
Parkinsons Disease Treatment and Management
Treatment may involve medications to increase dopamine levels, physical therapy, occupational therapy, and speech therapy. Additionally, deep brain stimulation may be considered for patients with advanced disease. Using the 5 Osteopathic Models, treatment plans may incorporate biomechanical, respiratory/circulatory, metabolic/energy, neurological, and behavioral models to address various aspects of the disease.
Motor Neurone Disease (MND) Pathophysiology
Motor Neuron Disease is a group of progressive neurodegenerative disorders that primarily affect motor neurons, leading to muscle weakness, atrophy, and paralysis. The exact cause is not fully understood but may involve genetic, environmental, and cellular factors.
Motor Neurone Disease (MND) Epidemiology
Most cases of Motor Neuron Disease are of unknown cause, and only 10% are inherited. It is more prevalent with old age, with a typical range of onset between 20-70 years. The survival rate after diagnosis is poor, with only 25% surviving 5 years and 5-10% surviving 10 years.
Motor Neurone Disease (MND) Signs and Symptoms
The signs and symptoms of Motor Neuron Disease include stumbling, difficulty holding objects, slurring of speech, swallowing difficulties, weakness of tongue and throat muscles, and cognitive changes. It typically has an insidious and mild onset.
Motor Neurone Disease (MND) Diagnosis
Diagnosis of Motor Neuron Disease is based on clinical history, examination, and electrophysiological tests such as EMG. Other tests may include blood tests, MRI, and muscle biopsy to document neurogenic denervation.
Motor Neurone Disease (MND) Treatment and Management
Treatment may involve medications to manage symptoms, assistive devices, physical and occupational therapy, speech therapy, and supportive care for symptom management. Using the 5 Osteopathic Models, treatment plans may address muscle weakness, respiratory function, nutritional intake, cognitive changes, and emotional support.
Alzheimers Disease (AD) Pathophysiology
Alzheimer's Disease is a neurodegenerative neurocognitive disorder without a cure, characterized by memory loss, cognitive decline, behavioral changes, and difficulties with self-care. It is the most common form of dementia.
Alzheimers Disease (AD) Epidemiology
Alzheimer's Disease primarily affects older adults, with the majority of cases occurring in individuals over the age of 65. The prevalence increases with age, and it can also affect individuals in their 40s and 50s. Possible comorbidities include T2DM, CVD, HT, depression, GIT disease, and IBD.
Alzheimers Disease (AD) Signs and Symptoms
The signs and symptoms of Alzheimer's Disease include memory loss, cognitive decline, disorientation, behavioral changes, and difficulty with self-care. It can be associated with comorbidities such as T2DM, CVD, HT, depression, GIT disease, and IBD.
Alzheimers Disease (AD) Diagnosis
Diagnosis of Alzheimer's Disease may involve genetic testing, blood tests for biomarkers, cognitive tests, and brain imaging such as MRI and PET scans to assess brain atrophy and concentration of molecules.
Alzheimers Disease (AD) Treatment and Management
Treatment may involve medications to improve cognitive function, supportive care and therapies, behavioral and environmental interventions, and caregiver support and education. Using the 5 Osteopathic Models, treatment plans may incorporate biomechanical, respiratory/circulatory, metabolic/energy, neurological, and behavioral models to address various aspects of the disease.
Myasthenia Gravis (MG) Pathophysiology
Myasthenia Gravis is an autoimmune neuromuscular disorder characterized by the transmission of nerve signals to muscles being affected by autoantibodies that target and block acetylcholine receptors at the neuromuscular junction, leading to muscle weakness and fatigue.
Myasthenia Gravis (MG) Epidemiology
Myasthenia Gravis can affect individuals of all ages and backgrounds, but it is more common in women under 40 and men over 60. It is most common in women of African descent.
Myasthenia Gravis (MG) Signs and Symptoms
The signs and symptoms of Myasthenia Gravis include muscle weakness, fatigue, drooping eyelids, double vision, difficulty swallowing and speaking, and limb weakness. Severe cases may involve respiratory muscle involvement.
Myasthenia Gravis (MG) Diagnosis
Diagnosis of Myasthenia Gravis is based on the characteristic distribution of muscle weakness, neurological examination, blood analysis, EMG, repetitive nerve stimulation tests, and imaging such as MRI and CT scans for thymus abnormalities.
Myasthenia Gravis (MG) Treatment and Management
Treatment may involve medications such as acetylcholinesterase inhibitors, immunosuppressants, and thymectomy in cases with thymic abnormalities. Supportive measures and lifestyle modifications are also utilized to address specific symptoms and conserve energy.
Untitled Deck
Study
Asthma Pathophysiology
Asthma is a chronic respiratory condition characterized by inflammation and narrowing of the airways. It involves airway inflammation, bronchoconstriction, and excess mucus production, resulting in wheezing, shortness of breath, coughing, and chest tightness. Reversible airflow obstruction is a hallmark for asthma.
Asthma Epidemiology
Asthma is common in children and can affect any age, with a prevalence of 1 in 10 in Australia. It can be influenced by factors such as genetics, environmental exposures, and lifestyle. Signs and symptoms include wheezing, shortness of breath, nonproductive cough, chest tightness, and symptoms that vary over time and in intensity.
Asthma Diagnosis
There is no specific test for asthma diagnosis, but it may involve pulmonary function tests, chest radiograph, HRCT scan, PET scan, and MRI. Treatment and management include controller medications, quick-relief medications, and identifying and avoiding triggers, as well as developing and following an asthma action plan.
Asthma Treatment - 5 Osteopathic Models
The treatment plan using the 5 osteopathic models for asthma includes incorporating breathing exercises, respiratory muscle training, physical activity, nutritional support, stress management, and education on asthma management and lifestyle changes.
COPD Pathophysiology
COPD is a progressive lung disease characterized by chronic bronchitis and emphysema. It is primarily caused by exposure to irritants, particularly smoking, and results in irreversible airflow obstruction. Patients with COPD often have multiple comorbidities such as atherosclerosis, hyperglycemia, hypertension, dyslipidemia, and osteoporosis.
COPD Epidemiology
COPD is prevalent in individuals over 40 years, and most patients have multiple comorbidities. Signs and symptoms include shortness of breath, persistent productive cough, wheezing, chest tightness, reduced exercise tolerance, and other respiratory and cardiovascular complications.
COPD Diagnosis
Diagnosis involves pulmonary function tests, arterial blood gas, ECG, chest radiography, and HRCT. Treatment and management include smoking cessation, medications, pulmonary rehabilitation, oxygen therapy, and lifestyle modifications.
COPD Treatment - 5 Osteopathic Models
The treatment plan using the 5 osteopathic models for COPD includes incorporating breathing exercises, physical activity, nutritional support, stress management, and education on COPD management and lifestyle changes.
Cystic Fibrosis Pathophysiology
Cystic Fibrosis is a genetic disorder characterized by defective CFTR protein, resulting in the buildup of thick and sticky mucus in the airways and digestive system. It leads to chronic lung infections, respiratory problems, and digestive issues. Early intervention is crucial to prevent irreversible lung damage.
Cystic Fibrosis Epidemiology
Cystic Fibrosis is common in children of Northern European descent, with a prevalence of 1 in 2800 in Australia. Signs and symptoms include chronic cough, difficulty breathing, excessive mucus production, digestive problems, and other systemic manifestations.
Cystic Fibrosis Diagnosis
Diagnosis involves tests such as the heel prick test, sweat chloride test, genetic test, sputum test, and various imaging scans. Treatment and management include airway clearance techniques, medications, nutritional support, and lung transplant for severe cases.
Cystic Fibrosis Treatment - 5 Osteopathic Models
The treatment plan using the 5 osteopathic models for Cystic Fibrosis includes incorporating airway clearance techniques, physical activity, nutritional support, stress management, and education on Cystic Fibrosis management and lifestyle changes.
Community Acquired Pneumonia (CAP) Pathophysiology
CAP is a lower respiratory tract infection characterized by the filling of air sacs in the lower lung with fluid/pus. It is a common respiratory infection that can affect individuals of all ages, with risk factors including age, underlying health conditions, smoking, and exposure to infectious agents.
CAP Signs and Symptoms
Signs and symptoms of CAP include cough with yellow or green mucus, fever, chills, shortness of breath, chest pain, fatigue, weakness, confusion in the elderly, and bluish discoloration of the lips and nail beds in severe cases.
CAP Diagnosis
Diagnosis may involve blood tests, nasal swab influenza, pulse oximetry, sputum culture, bronchoscopy, chest X-ray, and CT scan. Treatment and management include antibiotics, antivirals, antifungals, supportive care, and oxygen therapy for severe cases.
CAP Treatment - 5 Osteopathic Models
The treatment plan using the 5 osteopathic models for CAP includes incorporating deep breathing exercises, mobility, physical activity, nutritional support, stress management, and education on pneumonia management and lifestyle changes.
Untitled Deck
Study
GORD Pathophysiology
A chronic condition characterized by the backflow of stomach contents into the esophagus due to a weakened lower esophageal sphincter (LES). The acidic stomach contents lead to inflammation and mucosal damage. Risk factors include obesity, smoking, and dietary factors. Signs and symptoms include heartburn, acid reflux, cough, laryngitis, asthma, dental erosion, and epigastric pain. Diagnosis involves case history, PPI trial, ambulatory pH monitoring, endoscopy, and barium meal X-ray. Management includes lifestyle modifications, medications, and surgery if needed.
GERD Epidemiology
About 10-30% of people experience GORD, with 11.6% prevalence in Australia. Obesity, smoking, and dietary factors are known risk factors for developing GERD.
GERD Signs and Symptoms
Signs and symptoms of GORD include heartburn, acid reflux, oesophagitis, cough, laryngitis, asthma, dental erosion, epigastric pain, nausea, bloating, and bad breath.
GERD Diagnosis
Diagnosis is based on case history, symptoms like heartburn and regurgitation, anemia, dysphagia, melaena, and persistent vomiting. It includes a PPI trial, ambulatory pH monitoring, endoscopy, and barium meal X-ray.
GERD Treatment
Lifestyle modifications such as dietary changes, weight management, and elevation of the head of the bed are recommended. Medications include antacids, H2 receptor antagonists, and proton pump inhibitors (PPIs). Surgery may be considered in severe cases.
Coeliac Disease Pathophysiology
An autoimmune disorder triggered by the consumption of gluten, resulting in damage to the lining of the small intestine. Common signs and symptoms include gastrointestinal symptoms, malabsorption-related symptoms, skin rashes, joint pain, and neurological symptoms. Diagnosis involves blood tests, upper endoscopy with biopsy, and genetic testing. Management includes a gluten-free diet and supplementation for nutrient deficiencies.
Coeliac Disease Epidemiology
Celiac Disease is common, affecting about 1% of the general population.
Coeliac Disease Signs and Symptoms
Gastrointestinal symptoms include diarrhea, abdominal pain, bloating, and constipation. Malabsorption-related symptoms include weight loss, nutrient deficiencies, anemia, and fatigue. Nongastrointestinal symptoms include skin rashes, joint pain, easy bruising, headaches, T1DM, and neurological symptoms. Some individuals may be asymptomatic.
Coeliac Disease Diagnosis
Diagnosis involves blood tests for celiac-specific antibodies, upper endoscopy with biopsy, and genetic testing for HLADQ2 and HLADQ8.
Coeliac Disease Treatment
Management includes a gluten-free diet, supplementation for vitamin and mineral deficiency, and DMARDs (disease-modifying antirheumatic drugs), and glucocorticoids if needed.
Cholecystitis Cholelithiasis Pathophysiology
Cholecystitis is inflammation of the gallbladder, often caused by gallstones. Cholelithiasis is the presence of gallstones in the gallbladder. They are more prevalent in females, especially during their childbearing years, and in individuals who are overweight or obese.
Cholecystitis Cholelithiasis Signs and Symptoms
Signs and symptoms include right upper abdominal pain, nausea, vomiting, fever, chills, bloating, gas, and jaundice in severe cases.
Cholecystitis Cholelithiasis Diagnosis
Diagnosis involves Murphys sign, WBC, ESR, CRP, abdominal screening tenderness, abdominal ultrasound, and CT scan.
Cholecystitis Cholelithiasis Treatment
Treatment includes pain relief with medications, dietary modifications to reduce fat intake, and in cases of acute cholecystitis, hospitalization and possible cholecystectomy. Asymptomatic cholelithiasis may be managed with watchful waiting and monitoring.
Type 1 Diabetes T1DM Pathophysiology
T1DM is characterized by the destruction of insulin-producing beta cells in the pancreas, leading to insulin deficiency.
Type 1 Diabetes T1DM Epidemiology
T1DM is commonly diagnosed in childhood or early adulthood. The exact cause remains unclear but involves a combination of genetic predisposition and environmental triggers.
Type 1 Diabetes T1DM Signs and Symptoms
Signs and symptoms include polyuria, polydipsia, polyphagia, weight loss, fatigue, weakness, blurry vision, frequent infections, and in some cases, diabetic ketoacidosis (DKA).
Type 1 Diabetes T1DM Diagnosis
Diagnosis involves tests for random plasma glucose, fasting plasma glucose, plasma or urine ketones, C-peptides, and autoimmune markers.
Type 1 Diabetes T1DM Treatment
Treatment includes insulin administration, blood glucose monitoring, a well-balanced diet, and regular physical activity. Education and self-management are also important for patients to make informed decisions.
Type 2 Diabetes T2DM Pathophysiology
T2DM is characterized by insulin resistance and relative insulin deficiency. It is often associated with obesity, genetics, and lifestyle factors.
Type 2 Diabetes T2DM Epidemiology
T2DM is a common form of diabetes.
Untitled Deck
Study
Diverticulitis
Pathophysiology: Diverticulitis is a condition that occurs when small pouches (diverticula) in the walls of the colon become inflamed or infected. These pouches are often formed due to increased pressure on the colon wall and can trap stool, leading to inflammation or infection. Signs and symptoms: Abdominal pain, fever and chills, changes in bowel habits, bloating and gas, nausea and vomiting, rectal bleeding (in some cases). Diagnosis: FBC with differential, Urea, Electrolytes, CRP, Colonoscopy, CT Scan, X-ray. Treatment and management: Resolving inflammation, treating underlying infection, bowel rest, symptom relief, high fiber diet, physical exercise. Treatment Plan using the 5 Osteopathic Models: 1) Biomechanical Model, 2) Respiratory/Circulatory Model, 3) Metabolic/Energy Model, 4) Neurological Model, 5) Behavioral Model.
Crohn's Disease (CD)
Pathophysiology: Crohn's Disease is a chronic inflammatory bowel disease that can affect any part of the gastrointestinal tract. It is characterized by inflammation that extends through the full thickness of the bowel wall. Signs and symptoms: Abdominal pain, diarrhea (often bloody), weight loss, fatigue, inflammation and complications in other parts of the body. Diagnosis: FBC, CRP, ESR, Stool sample testing, Serum iron, Vit B12, X-ray, CT, MRI, US, Endoscopy. Treatment and management: Medications to reduce inflammation, dietary modifications, nutritional support, surgery (in cases of complications). Treatment Plan using the 5 Osteopathic Models: 1) Biomechanical Model, 2) Respiratory/Circulatory Model, 3) Metabolic/Energy Model, 4) Neurological Model, 5) Behavioral Model.
Ulcerative Colitis (UC)
Pathophysiology: UC is a chronic inflammatory bowel disease characterized by inflammation and ulcers in the innermost lining of the colon and rectum. Signs and symptoms: Diarrhea (often bloody), abdominal pain, rectal bleeding, urgency to have a bowel movement, weight loss, inflammation and complications in other parts of the body. Diagnosis: Stool studies, FBC, ESR, CRP, Biopsies, X-ray, Colonoscopy, CT Scan. Treatment and management: Medications to reduce inflammation, dietary modifications, nutritional support, surgery (in cases of complications). Treatment Plan using the 5 Osteopathic Models: 1) Biomechanical Model, 2) Respiratory/Circulatory Model, 3) Metabolic/Energy Model, 4) Neurological Model, 5) Behavioral Model.
Irritable Bowel Syndrome (IBS)
Pathophysiology: IBS is a chronic functional GI disorder characterized by recurring abdominal pain associated with bowel dysfunction. Epidemiology: More common in females, often associated with triggers like stress, PTSD, physical and sexual abuse. Signs and symptoms: Abdominal pain, abdominal bloating, passage of mucus with stool, urgency of defecation, lower quadrant tenderness. Diagnosis: No specific test, used to exclude other causes. Treatment and management: Dietary modifications, medications, stress management techniques, lifestyle changes. Treatment Plan using the 5 Osteopathic Models: 1) Biomechanical Model, 2) Respiratory/Circulatory Model, 3) Metabolic/Energy Model, 4) Neurological Model, 5) Behavioral Model.
Untitled Deck
Study
Metabolic Syndrome
Pathophysiology: Metabolic Syndrome is a cluster of conditions that increase the risk of heart disease, stroke, and type 2 diabetes. It involves insulin resistance, obesity, abnormal lipid metabolism, and hypertension. Results in insulin resistance and higher blood glucose levels. Epidemiology: Prevalence increases with age. Risk factors include smoking, obesity, heavy carb intake, sedentary lifestyle, alcohol intake, and family history. Associated conditions: Cardiovascular disease, stroke, type 2 diabetes, lifestyle cancers. Signs and symptoms: Increased waist circumference, BMI over 30, high blood pressure (130/85 mmHg), skin tags, fasting glucose over 100 mg/dL, insulin resistance, abnormal lipid profile, increased risk of blood clot formation, inflammation, abdominal pain, angina, polyuria, polydipsia, claudication. Diagnosis: International Diabetes Foundation criteria for diagnosis, waist circumference, fasting plasma glucose, low HDL cholesterol, liver and renal function tests, thyroid stimulating hormone, serum uric acid, fasting lipids, abdominal ultrasound, chest X-ray, ECG. Treatment and management: Lifestyle modifications, medications, and treatment using the 5 osteopathic models.
Non-Alcoholic Fatty Liver Disease (NAFLD)
Pathophysiology: It is a common cause of chronic liver disease worldwide and is characterized by the accumulation of fat in the liver in people who consume little or no alcohol. It may involve insulin resistance, metabolic syndrome, and inflammation. NAFLD can progress to nonalcoholic steatohepatitis (NASH) in some cases. Epidemiology: Strongly associated with obesity, type 2 diabetes, metabolic syndrome, hypertension, and rapid weight loss. Signs and symptoms: Asymptomatic, fatigue, malaise, abdominal pain, enlarged liver, hepatosplenomegaly, jaundice, altered mental state, ascites, peripheral edema, clubbing, bruising, alopecia, etc. Diagnosis: FBC, elevated liver enzyme levels, metabolic panel, lipid panel, total bilirubin, MRI, ultrasound. Treatment and management: Lifestyle modifications, management of comorbid conditions, monitoring and managing liver health, medications in some cases, and treatment using the 5 osteopathic models.
Renal Calculi (Kidney Stones)
Pathophysiology: Crystalline structures that form in the kidneys, often resulting from the concentration of certain minerals in the urine, inadequate fluid intake, and substances that promote crystal formation. Epidemiology: More common in individuals aged 40-50 years, and heat exposure and dehydration increase the risk. Associated with type 2 diabetes and obesity. Signs and symptoms: Acute severe flank pain, nausea, vomiting, urinary urgency and frequency, testicular pain, blood in urine, vague flank pain in upper abdomen. Diagnosis: Urinalysis, FBC, serum chemistry, stone analysis, CT scan, renal ultrasound, X-ray. Treatment and management: Pain management, increasing fluid intake, medications, shock wave lithotripsy, or surgical removal in severe cases, and treatment using the 5 osteopathic models.
Acute Kidney Injury (AKI)
Pathophysiology: Acute renal failure is a sudden loss of kidney function, often resulting from decreased blood flow to the kidneys, damage to kidney tissue, or urinary tract obstruction. Epidemiology: More common in older individuals, particularly those over 65 years, and in individuals with a history of chronic kidney disease, heart failure, liver disease, and cognitive impairment. Signs and symptoms: Decreased urine output, swelling or edema, fatigue, weakness, confusion, altered mental status, nausea, vomiting, high blood pressure, brownish red colored urine, lack of appetite, muscle tenderness, etc. Diagnosis: Rise in serum creatinine, urine volume, urinalysis, blood culture, CRP, BP, HR, RR, ECG, chest X-ray, renal tract US, abdominal CT/MRI, cystoscopy. Treatment and management: Monitoring, treating underlying conditions, fluid and electrolyte management, and treatment using the 5 osteopathic models.
Untitled Deck
Study
Dysmenorrhea
Pathophysiology: Dysmenorrhea is a medical term for painful menstruation. There are two main types: primary and secondary. Primary dysmenorrhea occurs without any underlying medical condition and is believed to result from increased prostaglandin production in the uterine lining. Secondary dysmenorrhea is associated with an underlying medical condition such as endometriosis or fibroids that causes pain during menstruation.
Dysmenorrhea
Epidemiology: Primary dysmenorrhea often begins in adolescence and is most common in young adults (under 30 yrs). Secondary dysmenorrhea can affect women 30-40 yrs of various ages and is typically associated with specific medical conditions.
Dysmenorrhea
Signs and Symptoms: Primary dysmenorrhea may present with lower abdominal cramping, pain radiating to back or inner thigh, vomiting, nausea, diarrhea, fatigue, headache, and increased sensitivity to pain. Secondary dysmenorrhea may not be consistent to the menstrual cycle and can worsen as menses progresses. It may also feature irregular heavy bleeding, vaginal discharge, painful intercourse, and other symptoms.
Dysmenorrhea
Diagnosis: Diagnostic tests for dysmenorrhea may include FBC, ESR, CRP, genital swabs, serum or urine pregnancy test, transvaginal US, MRI, and laparoscopy to identify endometriosis.
Dysmenorrhea
Treatment and Management: Treatment may involve over-the-counter pain relievers, hormonal therapies, lifestyle modifications such as exercise, dietary changes, and heat therapy, as well as surgery or other interventions to address underlying causes in cases of secondary dysmenorrhea.
Endometriosis
Pathophysiology: Endometriosis is a chronic medical condition where tissue similar to the lining of the uterus (endometrium) grows outside the uterus. The exact cause of endometriosis is not fully understood but it is believed to involve retrograde menstruation (backward flow of menstrual blood) and immune system dysfunction.
Endometriosis
Epidemiology: Endometriosis is reported in 5-10% of women and is associated with genetic factors.
Endometriosis
Signs and Symptoms: Signs and symptoms of endometriosis may include pelvic pain, painful menstrual periods, pain during or after sexual intercourse, chronic pelvic pain not related to menstruation, heavy or irregular menstrual bleeding, infertility or difficulty becoming pregnant, back or leg pain, cyclic bladder or bowel symptoms, and other related symptoms.
Endometriosis
Diagnosis: Diagnostic tests for endometriosis may include blood tests, pelvic ultrasound, MRI, and other relevant investigations.
Endometriosis
Treatment and Management: Pain management, hormonal therapies, surgical interventions, fertility treatments, and lifestyle modifications are among the approaches used to manage endometriosis.
Polycystic Ovary Syndrome (PCOS)
Pathophysiology: PCOS is a hormonal disorder causing enlarged ovaries with small cysts on the outer edges. The exact cause of PCOS isn't well understood but may involve a combination of genetic and environmental factors.
Polycystic Ovary Syndrome (PCOS)
Epidemiology: PCOS is reported in 7-13% of women and is associated with insulin resistance, metabolic syndrome, NAFLD, and T2DM.
Polycystic Ovary Syndrome (PCOS)
Signs and Symptoms: Signs and symptoms of PCOS may include irregular cycles, difficulty getting pregnant, excessive hair growth, weight gain, thinning hair, oily skin or acne, and other related symptoms.
Polycystic Ovary Syndrome (PCOS)
Diagnosis: Diagnostic tests for PCOS may include blood tests, oral glucose test, fasting lipid panel, and pelvic ultrasound.
Polycystic Ovary Syndrome (PCOS)
Treatment and Management: Lifestyle modifications such as weight management, hormonal therapies, fertility treatments, medications to manage insulin resistance, and psychological support are among the approaches used to manage PCOS.
Prostate Disease
Pathophysiology: Prostate disease is characterized by the enlargement of the prostate due to obstruction to the bladder outlet and subsequent lower urinary tract symptoms (LUTS).
Prostate Disease
Epidemiology: Prostate disease is common in older men, with prevalence increasing with age, and may be associated with a history of benign prostate hyperplasia (BPH), smoking, male pattern baldness, and metabolic syndrome.
Prostate Disease
Signs and Symptoms: Signs and symptoms of prostate disease may include increased urinary frequency, urgency, weak urine stream, difficulty initiating urination, and other related symptoms.
Prostate Disease
Diagnosis: Diagnostic tests for prostate disease may include urinalysis, serum prostate-specific antigen (PSA), serum creatinine, abdominal/pelvic ultrasound, CT/MRI, and cystoscopy.
Prostate Disease
Treatment and Management: Treatment of prostate disease may involve coordinated care with a urologist to improve LUTS, storage, quality of life, manage erectile dysfunction, prevent complications, and may include behavioral and lifestyle interventions, drug therapy, and surgical options.
